JPRN-UMIN000027362尚未招募未知
Examination of the liver fibrosis improvement effect with the SGLT2 inhibitor for diabetes complicated by non-alcoholic steatohepatitis. - SGLT2 inhibitor for diabetes complicated by NASH.
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Contraindication for SGLT2 inhibitor. Ineligible patients by judgement of family doctor.
研究者
相似试验
已完成
不适用
Examination of liver function improvement effect by administering a Ipragliflozin.DiabeticJPRN-UMIN000016198agasaki University Hospital100
招募中
不适用
Study for the correlation between liver fibrosis, steatosis and prognosis of the patients by using abdominal ultrasonographyliver diseaseJPRN-UMIN000031374agoya University4,000
招募中
不适用
Efficacy of liver stiffness measurement by ultrasonography in pediatric liver diseasesPediatric liver diseaseJPRN-jRCTs042190056Honda Takashi200
尚未招募
不适用
Study for the correlation between liver fibrosis evaluated by using abdominal ultrasonography and prognosis in pediatric patients with liver diseasespediatric liver diseasesJPRN-UMIN000033123agoya University graduate school of medicine department of gastroenterology and hepatology200
尚未招募
不适用
A study of non invasive evaluation of liver fibrosis in patients with Hepatitis B Virus(HBV) monoinfection using Fibroscan (Transient Elastography)Hepatitis B Virus (HBV)Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12609000381280Alfred Hospital250